282 related articles for article (PubMed ID: 12687556)
1. Disruption of tumor necrosis factor receptor p55 impairs collagen turnover in experimentally induced sclerodermic skin fibroblasts.
Murota H; Hamasaki Y; Nakashima T; Yamamoto K; Katayama I; Matsuyama T
Arthritis Rheum; 2003 Apr; 48(4):1117-25. PubMed ID: 12687556
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma.
Chan ES; Fernandez P; Merchant AA; Montesinos MC; Trzaska S; Desai A; Tung CF; Khoa DN; Pillinger MH; Reiss AB; Tomic-Canic M; Chen JF; Schwarzschild MA; Cronstein BN
Arthritis Rheum; 2006 Aug; 54(8):2632-42. PubMed ID: 16871530
[TBL] [Abstract][Full Text] [Related]
3. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.
Yoshizaki A; Yanaba K; Yoshizaki A; Iwata Y; Komura K; Ogawa F; Takenaka M; Shimizu K; Asano Y; Hasegawa M; Fujimoto M; Sato S
Arthritis Rheum; 2010 Aug; 62(8):2476-87. PubMed ID: 20506342
[TBL] [Abstract][Full Text] [Related]
4. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
[TBL] [Abstract][Full Text] [Related]
5. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis.
Huber LC; Distler JH; Moritz F; Hemmatazad H; Hauser T; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Distler O; Jüngel A
Arthritis Rheum; 2007 Aug; 56(8):2755-64. PubMed ID: 17665426
[TBL] [Abstract][Full Text] [Related]
6. Loss of beta1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse model.
Liu S; Kapoor M; Denton CP; Abraham DJ; Leask A
Arthritis Rheum; 2009 Sep; 60(9):2817-21. PubMed ID: 19714619
[TBL] [Abstract][Full Text] [Related]
7. Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis.
Kapoor M; McCann M; Liu S; Huh K; Denton CP; Abraham DJ; Leask A
Arthritis Rheum; 2009 Sep; 60(9):2822-9. PubMed ID: 19714649
[TBL] [Abstract][Full Text] [Related]
8. Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model.
Stegemann A; Sindrilaru A; Eckes B; del Rey A; Heinick A; Schulte JS; Müller FU; Grando SA; Fiebich BL; Scharffetter-Kochanek K; Luger TA; Böhm M
Arthritis Rheum; 2013 Mar; 65(3):792-804. PubMed ID: 23440693
[TBL] [Abstract][Full Text] [Related]
9. Investigation of sensory neurogenic components in a bleomycin-induced scleroderma model using transient receptor potential vanilloid 1 receptor- and calcitonin gene-related peptide-knockout mice.
Szabó A; Czirják L; Sándor Z; Helyes Z; László T; Elekes K; Czömpöly T; Starr A; Brain S; Szolcsányi J; Pintér E
Arthritis Rheum; 2008 Jan; 58(1):292-301. PubMed ID: 18163477
[TBL] [Abstract][Full Text] [Related]
10. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.
Hasegawa M; Matsushita Y; Horikawa M; Higashi K; Tomigahara Y; Kaneko H; Shirasaki F; Fujimoto M; Takehara K; Sato S
Arthritis Rheum; 2009 Nov; 60(11):3465-75. PubMed ID: 19877032
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
12. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
[TBL] [Abstract][Full Text] [Related]
14. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
[TBL] [Abstract][Full Text] [Related]
16. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
17. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
Yamamoto T; Nishioka K
Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
[TBL] [Abstract][Full Text] [Related]
18. Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F(2α) synthesis through adipose triglyceride lipase/calcium-independent phospholipase A(2).
Kanno Y; Kawashita E; Kokado A; Okada K; Ueshima S; Matsuo O; Matsuno H
Arthritis Rheum; 2013 Feb; 65(2):492-502. PubMed ID: 23124680
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma.
Kohno S; Endo H; Hashimoto A; Hayashi I; Murakami Y; Kitasato H; Kojima F; Kawai S; Kondo H
Biomed Pharmacother; 2006 Jan; 60(1):18-25. PubMed ID: 16337105
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
